Here is a link to press release regarding a Phase 2 PD trial that is recruiting in the United States - currently two centers - one in Arizona and one in Michigan. It is for early PD and excludes anyone receiving anti-parkinsonian therapy. Also you cannot expect to require anti-parkinsonian therapy for the duration of the study. There is a link to the study on clinicaltrials.gov within the press release.
Cerevance Doses First Patient in ASCEND P... - Cure Parkinson's
Cerevance Doses First Patient in ASCEND Phase 2 Clinical Study of CVN424, a First-in-Class, Non-Dopaminergic Therapy for the Treatment PD
Written by
Canddy
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
New Clinical Trial Starting: A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) (REGENERATE-PD)
Here is a link to the trial on clinicaltrials.gov...
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
Highlights
• Oral NR increases brain NAD levels in individuals with Parkinson’s disease
• NR...
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107,ERK inhibitor that selectively inhibits neuroinflammation
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107 (an ERK inhibitor...
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
This trial is already open in the United States, and I believe some on this forum are...
AnnovisBio has initiated a 6-month Phase 3 study to evaluate 2 different doses Buntanetap (posiphen) in 450 participants with PD
AnnovisBio has initiated a 6-month, placebo-controlled, double-blind Phase 2 study to evaluate...
Related Posts
Positive results for Cerevance’s Parkinson’s drug, phase 2 of CVN424 a GPR6 inverse agonist
Long-lasting response to levodopa in Parkinson's. Another important discovery funded by the Grigioni FoundationTuesday, 07 July 2020.
Taiwan reveals new findings to treat Parkinson's disease
Feedback from a PD research scientist in the department of Clinical Neuroscience at the University of Cambridge (UK), on PASADENA Trial...- Stem Cells Trials
